Analysis of Montelukast Sodium Using Prominence-i and Nexera-i MT
Applications | 2017 | ShimadzuInstrumentation
HPLC
IndustriesPharma & Biopharma
ManufacturerShimadzu
Key wordsmontelukast, sodium, impurity, nexera, prominence, passed, suitability, system, judgements, acto, using, adjustment, mau, resolution, test, indicates, hplc, listed, gradient, method, structural, news, repeatability, substances, function, harmonized, related, uhplc, example, harmonization, drug, requirements, formulae, chromatogram, pharmacopoeia, standard, flow, transfer, rsd, area, introduce, channels, liquid, introduces, between, article, volume, without, already, correction
Similar PDF
Analysis of Montelukast Sodium Using Prominence-i and Nexera-i MT
2017|Shimadzu|Applications
LAAN-A-LC-E295 Application News No. L520 High Performance Liquid Chromatography Analysis of Montelukast Sodium Using Prominence-i and Nexera-i MT Montelukast sodium is used as a therapeutic drug for treating bronchial asthma and allergic rhinitis, and is listed in the 17th edition…
Key words
montelukast, montelukastsodium, sodiumimpurity, impuritynexera, nexeraprominence, prominencepassed, passedsuitability, suitabilitysystem, systemjudgements, judgementsacto, actousing, usingadjustment, adjustmentmau, mauothertrade, othertradethannames
Solutions for Pharmaceutical Analysis - Application Notebook
2018|Shimadzu|ApplicationsGuides
C10G-E056 Solutions for Pharmaceutical Analysis Application Notebook First Edition: March, 2018 © Shimadzu Corporation, 2018 Solutions for Pharmaceutical Analysis Index Application Notebook Basic Research and Drug Discovery Development of a Phospholipid Profiling Method Using Triple Quadrupole LC-MS/MS This article shows…
Key words
sfc, sfcanalysis, analysischiral, chiralnews, newsphospholipid, phospholipidsystem, systemnexera, nexeramontelukast, montelukastomeprazole, omeprazolecolumn, columnflowrate, flowrateacetylcholine, acetylcholinephospholipids, phospholipidsthr, thrpde
Analysis of Meloxicam in Accordance with the United States Pharmacopoeia by Nexera XR
2019|Shimadzu|Applications
LAAN-A-LC-E323 Application News No. High Performance Liquid Chromatography Analysis of Meloxicam in Accordance with the United States Pharmacopoeia by NexeraTM XR L550 mAU 220 Meloxicam, inhibits the biosynthesis of prostaglandin, is utilized as an anti-inflammatory and analgesic for arthritis. In…
Key words
meloxicam, meloxicammau, maupassed, passedsuitability, suitabilityjudgement, judgementacto, actocompatibility, compatibilityrelated, relateditems, itemssolutiona, solutionabetween, betweensolution, solutionresult, resulttest, testprominencetm
Shimadzu LC Systems: Nexera-i and Prominence-i, i-Series Plus
2019|Shimadzu|Brochures and specifications
C196-E091B LC Systems Nexera-i Prominence-i -Series Plus intuitive Achieving Easier Operation innovative Advanced Interactive Design intelligent Smart Features Increase Work Efficiency Shimadzu's integrated LC system has been reborn as i-Series Plus. Equipped with ACTO technology for even smoother migration of…
Key words
acto, actoseries, seriesplus, plusprominence, prominencemethod, methodadjustment, adjustmentfunction, functionsystem, systempretreatment, pretreatmentscouting, scoutingnexera, nexeramin, minsystems, systemsmobile, mobilemannitol